| Ytd | 27.66% | |
| 1y | 55.06% |
| Open | 33.83 | Prev Close | 35.66 | Low | 33.37 | High | 36.09 | Mkt Cap | 2.37B |
| Vol | 1.30M | Avg Vol | 948.69K | EPS | -4.26 | P/E | -8.37 | Forward P/E | -8.69 |
| Beta | 0.90 | Short Ratio | 5.97 | Inst. Own | 95.89% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 33.40 | 200-d Avg | 29.26 | 1yr Est | 57.53 |
CLDX News
Celldex Therapeutics, Inc. (CLDX) Discusses Phase II Barzolvolimab Results in Prurigo Nodularis and
Pegasystems Inc (NASDAQ: PEGA) reported lower-than-expected earnings and sales, causing stocks to fa
Celldex Therapeutics Inc. (NASDAQ:CLDX) on Tuesday said it is ending its Phase 2 clinical trial eval
Celldex Therapeutics NASDAQ: CLDX said a Phase 2 trial of barzolvolimab in prurigo nodularis did not
Celldex Therapeutics said on Tuesday it would discontinue the development of its experimental drug
HAMPTON, N.J., July 21, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) today reported topline result
Guggenheim analyst Yatin Suneja maintains Celldex Therapeutics (NASDAQ:CLDX) with a Buy and raise
Celldex (NASDAQ:CLDX) announced today that Sam Martin, Senior Vice President and Chief Financial Off
HAMPTON, N.J., July 15, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that Sam Mart
HAMPTON, N.J., June 14, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today the presentat
HAMPTON, N.J., June 14, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) today presented positive resu
-- Flash talks on barzolvolimab clinical program in CSU and Cold Urticaria ---- Late-breaking poster
Celldex Therapeutics (CLDX) came out with a quarterly loss of $1.18 per share versus the Zacks Conse
HAMPTON, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) today reported financial resul
Celldex is positioned as a platform immunology company, leveraging barzolvolimab's mast-cell depleti
The mean of analysts' price targets for Celldex (CLDX) points to a 76.4% upside in the stock. While
Celldex Therapeutics (NASDAQ: CLDX) executives used an appearance at H.C. Wainwright's annual Inflam
HAMPTON, N.J., April 13, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that managem
SG Americas Securities LLC grew its position in Celldex Therapeutics, Inc. (NASDAQ: CLDX) by 143.2%
HAMPTON, N.J., April 06, 2026 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (“Celldex” or the “Comp
HAMPTON, N.J., April 01, 2026 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (“Celldex” or the “Comp
HAMPTON, N.J., April 01, 2026 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (“Celldex” or the “Comp
- Improvements seen across all six DLQI Domains indicating broad, beneficial impact on quality of li
Wall Street rebounded on Monday, recovering part of last week's steep losses as investors grew m
During the session on Thursday, 461 stocks hit new 52-week lows.
During Monday's trading, 1214 companies set new 52-week lows.
Before 10 a.m. ET on Thursday, 91 companies hit new 52-week highs.
During Monday's morning trading, 285 companies set new 52-week highs.
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Monday
Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018
Stocks Which Set New 52-Week Low Yesterday, October 11th